INTERPACE BIOSCIENCES, INC. (IDXGD) Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value

INTERPACE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value

INTERPACE BIOSCIENCES, INC. (IDXGD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $4.47 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2025-03-31

• INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2024 was $4.47, a 1.97% decline from fiscal 2023.
• INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2023 was $4.56, a 2.77% decline from fiscal 2022.
• INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2022 was $4.69, a 18.01% decline from fiscal 2021.
• INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2021 was $5.72, a 27.23% decline from fiscal 2020.